Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dynavax Technologies Corp (NASDAQ:DVAX)

6.05
BATS BZX Real-Time Price
As of 2:29pm ET
 +0.05 / +0.83%
Today’s Change
3.20
Today|||52-Week Range
23.62
+53.16%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close6.00
Today’s open5.90
Day’s range5.90 - 6.20
Volume78,441
Average volume (3 months)1,851,936
Market cap$266.1M
Dividend yield--
Data as of 2:29pm ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)+10.15%
Earnings growth (this year)+29.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+172.67%
P/E ratioNM
Price/Sales13.77
Price/Book2.60

Competitors

 Today’s
change
Today’s
% change
OCULOcular Therapeutix I...+0.13+1.40%
NERVMinerva Neuroscience...+0.53+6.91%
ZGNXZogenix Inc+0.30+2.87%
ZYNEZynerba Pharmaceutic...+1.28+6.51%
Data as of 2:31pm ET, 03/27/2017

Financials

Next reporting dateMay 8, 2017
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$11.0M
Annual profit (last year)-$112.4M
Net profit margin-1,018.24%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts


Search for Jobs